Daniela Ponce-Balbuena1, Guadalupe Guerrero-Serna1, Carmen R Valdivia1, Ricardo Caballero2,3, F Javier Diez-Guerra4, Eric N Jiménez-Vázquez1, Rafael J Ramírez1, André Monteiro da Rocha1, Todd J Herron1, Katherine F Campbell1, B Cicero Willis1, Francisco J Alvarado5, Manuel Zarzoso1, Kuljeet Kaur1, Marta Pérez-Hernández2,3, Marcos Matamoros2,3, Héctor H Valdivia1,5, Eva Delpón2,3, José Jalife6,7,8. 1. From the Department of Internal Medicine and Center for Arrhythmia Research (D.P.-B., G.G.-S., C.R.V., E.N.J.-V., R.J.R., A.M.d.R., T.J.H., K.F.C., B.C.W., M.Z., K.K., H.H.V., J.J.). 2. Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid, Spain (R.C., M.P.-H., M.M., E.D.). 3. Instituto de Investigación Sanitaria Gregorio Marañón, School of Medicine, Universidad Complutense, Madrid, Spain (R.C., M.P.-H., M.M., E.D.). 4. Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (UAM-CSIC), Universidad Autónoma de Madrid, Spain (F.J.D.-G.). 5. Department of Molecular and Integrative Physiology (F.J.A., H.H.V.). 6. From the Department of Internal Medicine and Center for Arrhythmia Research (D.P.-B., G.G.-S., C.R.V., E.N.J.-V., R.J.R., A.M.d.R., T.J.H., K.F.C., B.C.W., M.Z., K.K., H.H.V., J.J.) jjalife@umich.edu. 7. University of Michigan, Ann Arbor; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (J.J.). 8. CIBERV, Madrid, Spain (J.J.).
Abstract
RATIONALE: In cardiomyocytes, NaV1.5 and Kir2.1 channels interact dynamically as part of membrane bound macromolecular complexes. OBJECTIVE: The objective of this study was to test whether NaV1.5 and Kir2.1 preassemble during early forward trafficking and travel together to common membrane microdomains. METHODS AND RESULTS: In patch-clamp experiments, coexpression of trafficking-deficient mutants Kir2.1Δ314-315 or Kir2.1R44A/R46A with wild-type (WT) NaV1.5WT in heterologous cells reduced inward sodium current compared with NaV1.5WT alone or coexpressed with Kir2.1WT. In cell surface biotinylation experiments, expression of Kir2.1Δ314-315 reduced NaV1.5 channel surface expression. Glycosylation analysis suggested that NaV1.5WT and Kir2.1WT channels associate early in their biosynthetic pathway, and fluorescence recovery after photobleaching experiments demonstrated that coexpression with Kir2.1 increased cytoplasmic mobility of NaV1.5WT, and vice versa, whereas coexpression with Kir2.1Δ314-315 reduced mobility of both channels. Viral gene transfer of Kir2.1Δ314-315 in adult rat ventricular myocytes and human induced pluripotent stem cell-derived cardiomyocytes reduced inward rectifier potassium current and inward sodium current, maximum diastolic potential and action potential depolarization rate, and increased action potential duration. On immunostaining, the AP1 (adaptor protein complex 1) colocalized with NaV1.5WT and Kir2.1WT within areas corresponding to t-tubules and intercalated discs. Like Kir2.1WT, NaV1.5WT coimmunoprecipitated with AP1. Site-directed mutagenesis revealed that NaV1.5WT channels interact with AP1 through the NaV1.5Y1810 residue, suggesting that, like for Kir2.1WT, AP1 can mark NaV1.5 channels for incorporation into clathrin-coated vesicles at the trans-Golgi. Silencing the AP1 ϒ-adaptin subunit in human induced pluripotent stem cell-derived cardiomyocytes reduced inward rectifier potassium current, inward sodium current, and maximum diastolic potential and impaired rate-dependent action potential duration adaptation. CONCLUSIONS: The NaV1.5-Kir2.1 macromolecular complex pre-assembles early in the forward trafficking pathway. Therefore, disruption of Kir2.1 trafficking in cardiomyocytes affects trafficking of NaV1.5, which may have important implications in the mechanisms of arrhythmias in inheritable cardiac diseases.
RATIONALE: In cardiomyocytes, NaV1.5 and Kir2.1 channels interact dynamically as part of membrane bound macromolecular complexes. OBJECTIVE: The objective of this study was to test whether NaV1.5 and Kir2.1 preassemble during early forward trafficking and travel together to common membrane microdomains. METHODS AND RESULTS: In patch-clamp experiments, coexpression of trafficking-deficient mutants Kir2.1Δ314-315 or Kir2.1R44A/R46A with wild-type (WT) NaV1.5WT in heterologous cells reduced inward sodium current compared with NaV1.5WT alone or coexpressed with Kir2.1WT. In cell surface biotinylation experiments, expression of Kir2.1Δ314-315 reduced NaV1.5 channel surface expression. Glycosylation analysis suggested that NaV1.5WT and Kir2.1WT channels associate early in their biosynthetic pathway, and fluorescence recovery after photobleaching experiments demonstrated that coexpression with Kir2.1 increased cytoplasmic mobility of NaV1.5WT, and vice versa, whereas coexpression with Kir2.1Δ314-315 reduced mobility of both channels. Viral gene transfer of Kir2.1Δ314-315 in adult rat ventricular myocytes and human induced pluripotent stem cell-derived cardiomyocytes reduced inward rectifier potassium current and inward sodium current, maximum diastolic potential and action potential depolarization rate, and increased action potential duration. On immunostaining, the AP1 (adaptor protein complex 1) colocalized with NaV1.5WT and Kir2.1WT within areas corresponding to t-tubules and intercalated discs. Like Kir2.1WT, NaV1.5WT coimmunoprecipitated with AP1. Site-directed mutagenesis revealed that NaV1.5WT channels interact with AP1 through the NaV1.5Y1810 residue, suggesting that, like for Kir2.1WT, AP1 can mark NaV1.5 channels for incorporation into clathrin-coated vesicles at the trans-Golgi. Silencing the AP1 ϒ-adaptin subunit in human induced pluripotent stem cell-derived cardiomyocytes reduced inward rectifier potassium current, inward sodium current, and maximum diastolic potential and impaired rate-dependent action potential duration adaptation. CONCLUSIONS: The NaV1.5-Kir2.1 macromolecular complex pre-assembles early in the forward trafficking pathway. Therefore, disruption of Kir2.1 trafficking in cardiomyocytes affects trafficking of NaV1.5, which may have important implications in the mechanisms of arrhythmias in inheritable cardiac diseases.
Authors: Diana Shy; Ludovic Gillet; Jakob Ogrodnik; Maxime Albesa; Arie O Verkerk; Rianne Wolswinkel; Jean-Sébastien Rougier; Julien Barc; Maria C Essers; Ninda Syam; Roos F Marsman; Anneke M van Mil; Samuel Rotman; Richard Redon; Connie R Bezzina; Carol Ann Remme; Hugues Abriel Journal: Circulation Date: 2014-06-03 Impact factor: 29.690
Authors: Jean-Sébastien Rougier; Miguel X van Bemmelen; M Christine Bruce; Thomas Jespersen; Bruno Gavillet; Florine Apothéloz; Sophie Cordonier; Olivier Staub; Daniela Rotin; Hugues Abriel Journal: Am J Physiol Cell Physiol Date: 2004-11-17 Impact factor: 4.249
Authors: Marta Pérez-Hernández; Marcos Matamoros; Silvia Alfayate; Paloma Nieto-Marín; Raquel G Utrilla; David Tinaquero; Raquel de Andrés; Teresa Crespo; Daniela Ponce-Balbuena; B Cicero Willis; Eric N Jiménez-Vazquez; Guadalupe Guerrero-Serna; Andre M da Rocha; Katherine Campbell; Todd J Herron; F Javier Díez-Guerra; Juan Tamargo; José Jalife; Ricardo Caballero; Eva Delpón Journal: JCI Insight Date: 2018-09-20
Authors: Ellen R Lubbers; Nathaniel P Murphy; Hassan Musa; Claire Yu-Mei Huang; Rohan Gupta; Morgan V Price; Mei Han; Georges Daoud; Daniel Gratz; Mona El Refaey; Xianyao Xu; Nicole K Hoeflinger; Emma L Friel; Peter Lancione; Michael J Wallace; Omer Cavus; Samantha L Simmons; Jordan L Williams; Michel Skaf; Sara N Koenig; Paul M L Janssen; Matthew N Rasband; Thomas J Hund; Peter J Mohler Journal: J Biol Chem Date: 2019-05-07 Impact factor: 5.157
Authors: Sara Ballouz; Melissa M Mangala; Matthew D Perry; Stewart Heitmann; Jesse A Gillis; Adam P Hill; Jamie I Vandenberg Journal: Cardiovasc Res Date: 2021-08-29 Impact factor: 10.787
Authors: Bence Hegyi; Ye Chen-Izu; Leighton T Izu; Sridharan Rajamani; Luiz Belardinelli; Donald M Bers; Tamás Bányász Journal: Circ Arrhythm Electrophysiol Date: 2020-03-23